E-LIB Suche - Ergebnisse für: Marín Pozo, Juan Francisco

1

Real-world data of atezolizumab in patients with previously..:

Díaz Acedo, Rocío ; Galvan Banqueri, Mercedes ; Artacho Criado, Silvia...
International Journal of Clinical Pharmacy. 46 (2023) 2 - p. 382-389 , 2023

Link: https://doi.org/10.1007/..

2

Bevacizumab and aflibercept in second-line metastatic color..:

Claramunt García, Raquel ; Muñoz Cid, Carmen Lucía ; Sánchez Ruiz, Andrés.
European Journal of Clinical Pharmacology. 78 (2021) 2 - p. 287-291 , 2021

Link: https://doi.org/10.1007/..

3

A multicentre observational study of the effectiveness, saf..:

Merino Almazán, Macarena ; Duarte Pérez, Juan Manuel ; Marín Pozo, Juan Francisco...
International Journal of Clinical Pharmacy. 41 (2018) 1 - p. 272-279 , 2018

Link: https://doi.org/10.1007/..

4

P1.07-009 Outcomes of Patients with Relapsed Small-Cell Lun..:

Ortega Granados, Ana Laura ; Caro, Natalia Luque ; Marín Pozo, Juan Francisco...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S700-S701 , 2017

Link: https://doi.org/10.1016/..

5

P2.03a-047 Clinical Trial Participation and Outcomes in Non..:

Ortega Granados, Ana Laura ; De La Torre Cabrera, Capilla ; Quesada, Nuria Cárdenas...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S917-S918 , 2017

Link: https://doi.org/10.1016/..

6

Early use of tocilizumab in patients with severe pneumonia ..:

Sánchez-Rovira, Pedro ; Pérez-Chica, Gerardo ; Ortega-Granados, Ana Laura...
Medicine. 100 (2021) 29 - p. e26533 , 2021

Link: https://doi.org/10.1097/..

7

EVALUATION OF DOCETAXEL USE IN NON-SMALL CELL LUNG CANCER: ..:

Merino Almazan, Macarena ; Marin Pozo, Juan Francisco ; Duarte Perez, Juan Manuel
0014-8237. , 2021

Link: http://hdl.handle.net/10..

8

Safety, Effectiveness, and Costs of Bevacizumab-Based Thera..:

Marín Pozo, Juan Francisco ; Duarte Pérez, Juan Manuel ; Sánchez Rovira, Pedro
Martín-Pozo, J.F.; Duarte-Pérez, J.M.; Sánchez-Rovira, P. Safety, Effectiveness, and Costs of Bevacizumab-Based Therapy in Southern Spain: A Real World Experience. Medicine, 95(19): e3623 (2016). [http://hdl.handle.net/10481/44560]. , 2016

Link: http://hdl.handle.net/10..

9

Utilización de bevacizumab en pacientes oncológicos, estudi..:

Marín Pozo, Juan Francisco
Marín Pozo, J.F. Utilización de bevacizumab en pacientes oncológicos, estudio en fase IV: efectividad, seguridad e impacto farmacoeconómico (Estudio MAR-BEV-2013-01). Granada: Universidad de Granada, 2014. 157 p. [http://hdl.handle.net/10481/35173]. , 2014

Link: http://hdl.handle.net/10..

10

Early use of tocilizumab in patients with severe pneumonia ..:

Sánchez-Rovira, Pedro ; Pérez-Chica, Gerardo ; Ortega-Granados, Ana Laura...
http://hdl.handle.net/10668/18381. , 2021

Link: http://hdl.handle.net/10..

11

Deploying unsupervised clustering analysis to derive clinic..:

on behalf of COVID-19 SEMICYUC Working Group ; Rodríguez, Alejandro ; Ruiz-Botella, Manuel...
Critical Care. 25 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

12

Deploying unsupervised clustering analysis to derive clinic..:

Rodríguez, Alejandro ; Ruiz-Botella, Manuel ; Martín-Loeches, Ignacio...
http://hdl.handle.net/10668/17183. , 2021

Link: http://hdl.handle.net/10..

13

Deploying unsupervised clustering analysis to derive clinic..:

Rodríguez, Alejandro ; Ruiz-Botella, Manuel ; Martín-Loeches, Ignacio...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883885/. , 2021

Link: http://www.ncbi.nlm.nih...

14

New human combined immunodeficiency caused by interferon re..:

Bravo García-Morato, María ; Aracil Santos, Francisco Javier ; Briones, Alejandro Contreras...
Journal of Allergy and Clinical Immunology. 141 (2018) 5 - p. 1924-1927.e18 , 2018

Link: https://doi.org/10.1016/..

15

Additional file 1 of Deploying unsupervised clustering anal..:

Alejandro Rodríguez (10147451) ; Manuel Ruiz-Botella (10147454) ; Ignacio Martín-Loeches (10147457)...
https://figshare.com/articles/journal_contribution/Additional_file_1_of_Deploying_unsupervised_clustering_analysis_to_derive_clinical_phenotypes_and_risk_factors_associated_with_mortality_risk_in_2022_critically_ill_patients_with_COVID-19_in_Spain/14037836. , 2021

Link: https://doi.org/10.6084/..